Nektar Therapeutics | NKTR - 税前利润



金融业
股票价格
USD
资产
USD 763.27M
现金及等价物
USD 149.58M
销售成本
USD 4.44M
流动资产
USD 589.04M
流动负债
USD 57.71M
债务
USD 0
股息收益率
0
EBIT
USD -38.26M
EBITDA
USD -38.9M
员工
137
EPS每股收益
USD -1.78
股本和储备
USD 576.22M
销售毛利
USD 10.86M
债务利息支出
USD 7.94M
利息收入
USD -0.18
贷款资金
USD 60.27M
市值
USD 10.53B
净收入
USD -44.9M
营业费用
USD 49.12M
营业利润
USD -38.26M
普通股股本
USD 29.47M
税前利润
USD -43.09M
销售收入
USD 10.86M
销售和管理费用
USD 11.87M
股票
USD 14.46M
贸易债权人
USD 10.03M
应收帐款人
USD 3.6M


税前利润 更改 日
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
ALKERMES USD -61.93M 122.3M 2026-03
Alterity Therapeutics Limited AUD -6.26M 1.52M 2025-12
Amgen USD 2.08B 570M 2026-03
Baxter International USD 362M 368M 2026-06
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
Biogen USD 647.3M 269.6M 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Cara Therapeutics USD -6.8M 1.9M 2026-03
Cipla INR 10.82B 3.33B 2026-06
Dr.Reddys Laboratories INR 5.54B 955M 2026-06
Eisai JPY 25.28B 33.22B 2026-06
Eli Lilly USD 8.85B 583.8M 2026-03
Exelixis USD 262.68M 5.01M 2026-06
Gilead Sciences USD -7.53B 10.11B 2026-06
GlaxoSmithKline GBP 2.68B 532M 2026-06
Grifols EUR 257.85M 190.87M 2024-12
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
Incyte USD 751.51M 407.91M 2026-06
Ionis Pharmaceuticals USD -114M 21M 2026-06
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
Karyopharm Therapeutics USD -22.39M 17.51M 2026-03
MacroGenics USD -36.77M 21.84M 2026-03
Merck USD -3.53B 6.95B 2026-03
Nektar Therapeutics USD -43.09M 8.39M 2026-03
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
Novartis USD 4.27B 430M 2026-06
Pfizer USD -653M 5.84B 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sarepta Therapeutics USD -1.75M 344.92M 2026-06
Takeda JPY 162.72B 215.2B 2026-06
Teva Pharmaceutical Industries USD -455M 1.21B 2026-06
Xencor USD -21.92M 106.72M 2026-06